Tabor et al., 1976 - Google Patents
Induction of Antibody to the “y” Determinant of HBsAg in a Chimpanzee Carrier of HBsAg Subtype “adw”Tabor et al., 1976
- Document ID
- 6907582996991593987
- Author
- Tabor E
- Gerety R
- Smallwood L
- Barker L
- Publication year
- Publication venue
- The Journal of Immunology
External Links
Snippet
Antibody to the y determinant of hepatitis B surface antigen (HBsAg) was induced in a chimpanzee chronically infected with hepatitis B virus and circulating HBsAg subtype adw. The chimpanzee was immunized with purified preparations of HBsAg subtypes adw and …
- 108090001123 antibodies 0 title abstract description 26
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
- G01N33/5761—Hepatitis B
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Stiehm | Standard and special human immune serum globulins as therapeutic agents | |
Zajac et al. | Overview of clinical studies with hepatitis B vaccine made by recombinant DNA | |
Maruyama et al. | Distinguishing between acute and symptomatic chronic hepatitis B virus infection | |
Iwarson et al. | Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee | |
Dienstag et al. | Hepatitis B vaccine administered to chronic carriers of hepatitis B surface antigen | |
Holland et al. | Subtyping of hepatitis-associated antigen (HB Ag); simplified technique with counterelectrophoresis | |
Gerlich et al. | Selective detection of IgM‐antibody against core antigen of the hepatitis B virus by a modified enzyme immune assay | |
Williams et al. | Heterogeneity and thermolability of ‘e’ | |
Takahashi et al. | Shift from free “small” hepatitis B e antigen to IgG-bound “large” form in the circulation of human beings and a chimpanzee acutely infected with hepatitis B virus | |
Okamoto et al. | Antibody to the receptor for polymerized human serum albumin in acute and persistent infection with hepatitis B virus | |
Oldstone et al. | Effect of chronic viral infection on the immune system: I. comparison of the immune responsiveness of mice chronically infected with LCM virus with that of noninfected mice | |
Tabor et al. | Induction of Antibody to the “y” Determinant of HBsAg in a Chimpanzee Carrier of HBsAg Subtype “adw” | |
Murphy et al. | Viral subtypes and cross-protection in hepatitis B virus infections of chimpanzees | |
Gold et al. | Characterization of antibodies to the structural polypeptides of HBsAg: evidence for subtype-specific determinants | |
Steward et al. | Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions. | |
Stephan et al. | Modulation of hepatitis B infection by intravenous application of an immunoglobulin preparation that contains antibodies to hepatitis B e and core antigens but not to hepatitis B surface antigen | |
Gordon et al. | Distribution of hepatitis B antigenic determinants in different forms of viral hepatitis | |
SHINGU et al. | Menstrual abnormalities after hepatitis B vaccine | |
Ponzetto et al. | Antibody to the hepatitis B virus-associated delta-agent in immune serum globulins | |
Quinti et al. | Hepatitis C virus-specific B cell activation: IgG and IgM detection in acute and chronic hepatitis C | |
Prince et al. | A final report on safety and immunogenicity of a bivalent aqueous subunit HBV vaccine | |
Tsai et al. | Study of IgG subclass profiles of anti-HBs in populations with different HBV infection status | |
Hersh et al. | Australia antigen and antibody and alpha‐fetoglobulin in hepatoma patients | |
Hwang et al. | Immunogenicity of HBV vaccine in healthy Chinese children | |
Januszkiewicz et al. | Hepatitis B and C virus infection in Polish children with malignancies |